A detailed history of Neo Ivy Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 34,330 shares of MRK stock, worth $3.42 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares
34,330
Holding current value
$3.42 Million
% of portfolio
1.33%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$111.15 - $128.97 $3.82 Million - $4.43 Million
34,330 New
34,330 $3.9 Million
Q3 2022

Nov 15, 2022

SELL
$84.53 - $94.96 $65,341 - $73,404
-773 Reduced 29.48%
1,849 $159,000
Q2 2022

Aug 16, 2022

SELL
$83.49 - $94.64 $830,892 - $941,857
-9,952 Reduced 79.15%
2,622 $239,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $512,952 - $574,987
6,978 Added 124.7%
12,574 $1.03 Million
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $99,529 - $124,673
1,377 Added 32.64%
5,596 $428,000
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $267,315 - $370,512
4,219 New
4,219 $325,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.